Introduction
High fructose corn syrup (HFCS) was developed industrially as an alternative to sucrose in the USA over the period from 1970 to 1985 1) . In Japan, the consumption of HFCS has been increasing since 1980, while that of sucrose has decreased 2) , and HFCS currently accounts for approximately 40% of the total consumption of sugar, ranking just behind the USA 3) . The products in which HFCS is used include soft drinks, which account for approximately 50% of the total consumption of HFCS 2) . However, detailed research has not yet been conducted on the daily consumption of HFCS and fructose by Japanese people.
In the USA, many studies have shown a relationship between the intake of sugar-sweetened beverages and weight gain 4) , and the exaggerated postprandial triglyceride (TG) response observed following the ingestion of HFCS has been shown to be caused by assessed as the abdominal girth at the level of the umbilicus, and the hip circumference was measured at the level of the greater trochanters. The waist-to-hip (W/H) ratio was calculated. Body composition, including the visceral fat area (VFA), was analyzed using an eight-polar bioelectrical impedance method with the InBody720 (BioSpace, Tokyo, Japan).
Fructose, Glucose and the Fat Load Test
Each subject was studied on four occasions. At each test trial, the subjects ingested one of four beverages containing either fructose or glucose (0.5 g/kg body weight each) with or without oral fat tolerance test (OFTT) cream (Jomo, Takasaki, Japan; 1 g/kg, 0.35 g/kg as fat) in a randomized crossover design. OFTT cream was used as previously described [12] [13] [14] . The four beverages were prepared as follows: Fru: 0.5 g/kg of fructose (Nisshin Seito, Tokyo, Japan) mixed with no-sugar soda (Suntory, Tokyo, Japan); Fat: 1 g/ kg of OFTT cream; Fru+Fat: fructose (0.5 g/kg) mixed with no-sugar soda supplemented with OFTT cream (1 g/kg); Glu: 0.5 g/kg of glucose (1.5 mL/kg of Trelan-G75 TM , 1 g/3 mL as glucose, Ajinomoto, Tokyo, Japan). All beverages were used at a concentration of 10% (w/v).
Experimental Design
One of the four beverages mentioned above was administered after a 12-hour overnight fast. The subjects abstained from consuming caffeine or alcohol on the day before the experiment. Venous blood samples were obtained before (0 hours) and 0.5, 1, 2, 4 and 6 hours after ingestion. During the test, the subjects avoided exercise and eating, but had free access to water after one hour. All blood samples were obtained in the supine position. The experiments were conducted at least four weeks apart. There was an interval of four weeks between the test days to minimize the confounding effects of the subjects' menstrual status on lipid metabolism.
Biochemical Analysis
The serum samples were immediately refrigerated (4 ℃) or frozen (−80 ℃) until the analysis. Fructose was measured enzymatically (BioAssay Systems, CA, USA). Glucose was measured using a mutarotase GOD method (Wako, Osaka, Japan). Insulin was measured using a chemiluminescent enzyme immunoassay (Fujirebio, Tokyo, Japan). Insulin resistance was evaluated according to the homeostasis model assessment for insulin resistance (HOMA-IR) 15) . The hemoglobin A1c (HbA1c) level was measured using a latex agglutination method (Fujirebio) and expressed the fructose component 5) . Some studies have shown that the plasma concentration of TG increases significantly when fructose is ingested simultaneously with fat compared to that observed following fat intake only 6, 7) . Therefore, simultaneous ingestion of fructose and fat may possibly exacerbate postprandial lipidemia. The levels of triglyceride-rich lipoproteins (TRL), namely chylomicrons (CM), very-low-density lipoproteins (VLDL) and their remnants, increase in the postprandial state, and postprandial hyperlipidemia is known to be a major risk factor for coronary heart disease, as proposed by Zilversmit 8) . However, the influence of fructose intake on carbohydrate and lipid metabolism remains to be clarified, and very little information about the effects of fructose consumption on Japanese subjects is available. The World Health Organization has proposed that added sugars should provide no more than 10% of dietary energy 9) . At present, there are no evidencebased data regarding the upper limits of the intake of fructose, HFCS and sucrose for maintaining health in Japanese individuals 10) . The consumers with the highest intake of fructose in the USA are adolescents and young adults 11) , which is most likely also the case in Japan. Therefore, we enrolled young healthy Japanese women as subjects and examined the acute effects of fructose consumption on postprandial lipidemia.
Aim
To elucidate the effects of simultaneous ingestion of fructose and fat on postprandial lipoprotein metabolism in young healthy Japanese women.
Methods

Subjects
Nine young healthy Japanese women with a normal weight, a normal ovarian cycle and an apoE phenotype 3/3 phenotype were enrolled as participants. A normal weight was defined as a body mass index (BMI) of ≥ 18.5 kg/m 2 and ＜25 kg/m 2 . All of the subjects were nonsmokers, had no apparent acute or chronic illnesses and were not taking any medications or dietary supplements. This study was approved by the Institutional Review Board of the Sugiyama Jogakuen University School of Life Studies, and each subject provided their written informed consent for study participation.
Anthropometric and Body Composition Measurement
Body weight and height were measured according to standard methods. Waist circumference was statistical analyses were performed using the SPSS ver. 19 software program (IBM, Tokyo, Japan). Differences in the time course compared with the fasting values were analyzed using the Friedman test followed by the Wilcoxon signed-rank test with the Bonferroni correction. The measured differences in the values at each time point in the four trials were assessed using the Kruskal-Wallis test followed by the Mann-Whitney U-test with the Bonferroni correction.
Results
The physical characteristics and fasting blood chemical data of the subjects are shown in Table 1 . There were no significant differences in any of the physical characteristics between the four trials.
Fructose, Glucose, Insulin, FFA and Lactate
The serum concentrations of fasting and postprandial fructose, glucose, insulin, FFA and lactate in the four trials are presented in Table 2 .
The serum fructose concentrations in the Fru and Fru＋Fat trials were significantly increased at 0.5, 1 and 2 hours compared with each fasting value ( p＜ 0.05). The concentration of fructose in the Fru trial was significantly higher than that observed in the Fru ＋Fat trial at 0.5 hours ( p＜0.05). At 2 hours, the fructose concentration was still significantly higher in the Fru and Fru＋Fat trials compared with that observed in the Glu and Fat trials ( p＜0.05 each). The concentration of fructose in the Fru and Fru＋Fat trials fell to the fasting level at 4 hours.
The serum concentration of glucose in the Glu trial was significantly higher than that observed in the other three trials at 0.5 hours ( p＜0.05); however, it returned to the baseline value at 1 hour. Thereafter, there were no significant differences in the serum glucose concentration among the four trials.
The serum insulin concentration in the Glu trial was significantly higher than that observed in the other three trials at 0.5 hours ( p＜0.05). However, at 2 hours, there were no significant differences in the serum insulin concentration among the four trials, and no differences from the baseline values were observed.
The serum concentration of FFA instantly decreased in the Glu, Fru and Fru＋Fat trials, reaching a minimum at 1 hour. The FFA concentration in the Fru and Fru＋Fat trials was higher than that observed in the Glu trial at 1 (Fru vs. Glu p = 0.19, Fru＋Fat vs. Glu p = 0.06) and 2 hours (Fru vs. Glu p = 0.09, Fru＋ Fat vs. Glu p＜0.05). However, the FFA concentration in the Fat trial did not decrease after the fat load and as the National Glycohemoglobin Standardization Program (NGSP) value. The levels of free fatty acids (FFA) (Eiken Chemical, Tokyo, Japan) and lactate (Kyowa Medex, Tokyo, Japan) were measured enzymatically.
The level of total cholesterol (TC) was measured enzymatically (Sysmex, Hyogo, Japan). The level of high-density lipoprotein cholesterol (HDL-C) was measured using a direct method (Fujirebio). The level of low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula. The level of small, dense LDL-C (sdLDL-C) was measured enzymatically (Denka Seiken, Tokyo, Japan). The TG level was measured enzymatically (Sekisui Medical, Tokyo, Japan). The remnant-like particle TG (RLP-TG) level was measured using an immunosorbent assay (Otsuka Pharmaceutical, Tokyo, Japan). The remnant lipoprotein cholesterol (RemL-C) level was measured using a homogenous assay (MetaboRead TM , Kyowa Medex). In our previous studies, the serum concentration of RLP-C was measured using the immunoaffinity separation method 16) ; however, the RLP-C concentration measured using this method is sometimes less than the lower limit of detection in young Japanese women 14) . In the present study, the serum concentration of RemL-C was therefore measured using a newly developed homogenous assay 16) , and no samples were found to contain a concentration below the detection limit. The lipoprotein(a) (Lp(a)) level was measured using a latex agglutination method (Sekisui Medical). The levels of apolipoproteins (apos) AⅠ, AⅡ, CⅡ, CⅢ and E were measured using an immunoturbidimetric method (Sekisui Medical). The level of apoB48 was measured using a chemiluminescent enzyme immunoassay (Fujirebio). The apoE phenotype was measured using the isometric electrophoresis method (Phenotyping ApoE IEF System TM , Joko, Tokyo, Japan).
Quantification of Postprandial Metabolism
Postprandial metabolism was quantified by calculating the incremental area under the curve (⊿AUC), which was defined as the difference between the area under the curve and the area below the baseline (0 hours) concentration from 0 to 6 hours, as previously described 14) . Postprandial changes in the concentrations of TG, RLP-TG, RemL-C, apoB and apoB48 were calculated as the difference from the baseline mean value (as 0 at 0 hours) and shown as ⊿TG, ⊿ RLP-TG, ⊿RemL-C, ⊿apoB and ⊿apoB48, respectively.
Statistics
All data are expressed as the mean±SEM. The value at 4 hours in the Fat trial and at 6 hours in the Fru＋Fat trial. The ⊿AUC-TG in the Fru＋Fat trial was larger than that observed in the Fat trial ( p＜0.05) ( Table 3) . The ⊿RLP-TG peaked at 2 hours in the Fat trial and at 4 hours in the Fru＋Fat trial. The ⊿RLP-TG in the Fru＋Fat trial was higher than that observed in the Fat trial at 4 hours ( p＜0.05). At 6 hours, the ⊿RLP-TG in the Fat trial, but not that in the Fru＋Fat trial, returned to the baseline value. The ⊿AUC-RLP-TG in the Fru＋Fat trial had a tendency to be larger than that observed in the Fat trial ( p = 0.15) ( Table 3 ). The ⊿ RemL-C in the Fat trial peaked at 2 hours, then decreased and returned to the baseline value at 4 hours. In contrast, the ⊿RemL-C in the Fru＋Fat trial peaked at 4 hours and returned to the baseline value at 6 hours. The ⊿RemL-C in the Fru＋Fat trial was higher than that observed in the Fat trial at 4 hours ( p ＜0.05). The ⊿AUC-RemL-C in the Fru+Fat trial tended to be larger than that observed in the Fat trial ( p = 0.09) ( Table 3) .
ApoB and ApoB48
The concentrations of fasting and postprandial apoB and apoB48 in the four trials are presented in was higher than that observed in the other three trials at 1 and 2 hours ( p＜0.05 each).
The serum lactate concentration in the Fru and Fru＋Fat trials significantly increased at 1 hour compared with each fasting value ( p＜0.05). At 1 hour, the serum concentration of lactate in the Fru trial was higher than that observed in the Fat trial ( p＜0.05) and the lactate concentration in the Fru＋Fat trial was higher than that observed in the Glu and Fat trials ( p ＜0.05). However, there were no significant differences in the serum lactate concentration among the four trials thereafter.
TG, RLP-TG and RemL-C
The concentrations of fasting and postprandial TG, RLP-TG and RemL-C in the four trials are presented in Table 2 , and the time courses of ⊿TG, ⊿ RLP-TG and ⊿RemL-C are shown in Fig. 1A-C. ⊿ TG, ⊿RLP-TG and ⊿RemL-C were calculated because the baseline value of serum TG in the Glu trial was significantly lower than that in the Fru trial ( p＜0.05). ⊿TG peaked at 2 hours in the Fat trial and at 4 hours in the Fru＋Fat trial. The ⊿TG in the Fru＋Fat trial was higher than that observed in the Fat trial at 4 and 6 hours ( p＜0.05). The ⊿TG returned to the baseline Table 3) .
The ⊿apoB48 in the Fat trial tended to increase at 1 hour ( p = 0.11) and peaked at 2 hours. However, the ⊿apoB48 in the Fru＋Fat trial increased at 2 hours Table 2 , with the time courses of ⊿apoB and ⊿apoB48 shown in Fig. 1D & E. The ⊿apoB in the Fat, Fru＋Fat and Glu trials was not significantly different than the fasting values observed over 6 hours. In contrast, the ⊿apoB in the Fru trial increased after 6 hours ( p＜ In the present study, the ingestion of fructose combined with fat led to a significantly higher rise and delayed peak in the serum TG, RLP-TG and RemL-C concentrations compared with the ingestion of fat only. Insulin increases the expression and activity of lipoprotein lipase (LPL), and subjects who consume fructose have lower levels of postprandial LPL activity than subjects who consume glucose 22) . The lower insulin excursion observed following fructose compared with glucose ingestion may result in a reduced activation of LPL, thus leading to a delayed TG clearance 7) . An interesting finding of this study is the change in the concentration of apoB48 following the simultaneous ingestion of fructose and fat; the concentration of apoB48 significantly increased after 2 hours, and the peak was delayed compared with that observed following the ingestion of fat only, suggesting delayed intestinal absorption of dietary fat or secretion of CM from the intestine in addition to late clearance of intestinal TRL, namely CM and chylomicron-remnant (CM-R). The concentration of apoB48 observed following glucose intake was slightly but significantly increased at 1 hour, then declined steadily, falling below the baseline value at 6 hours, consistent with our previous results 23) . In contrast, the concentration of apoB48 did not change following fructose intake during the trial. These results suggest that the ingestion of glucose, but not fructose, may transiently stimulate the synthesis and/or secretion of intestinal apoB48-containing lipoproteins.
Although postprandial dyslipidemia was previously regarded to be a consequence of delayed TRL clearance, emerging evidence implicates intestinal overproduction of apoB48-containing lipoproteins as a major contributor to postprandial dyslipidemia 24) . In the present study, the concentration of apoB48 markedly increased and its peak was delayed following intake of fructose combined with fat compared with and peaked at 4 hours ( p＜0.05). The ⊿apoB48 in the Fru＋Fat trial was significantly higher than that observed in the Fat trial at 4 and 6 hours ( p＜0.05). The ⊿apoB48 in the Fat trial, but not that in the Fru ＋Fat trial, returned to the baseline value at 6 hours. The ⊿AUC-apoB48 in the Fru＋Fat trial was significantly larger than that observed in the Fat trial ( p＜ 0.05) ( Table 3 ). The ⊿apoB48 in the Glu trial was slightly but significantly increased at 1 and 2 hours, then slightly decreased, then fell significantly below the baseline value at 6 hours. In contrast, the ⊿apoB48 in the Fru trial was not significantly different from the fasting value observed during the trial.
Discussion
The major finding of this study is that simultaneous ingestion of fructose and fat markedly enhanced postprandial lipidemia in young healthy Japanese women. In this study, the subjects ingested a moderate amount of fructose (0.5 g/kg body weight). Although other studies have employed 0.75-1.5 g/kg of fructose 7, 17) , these high amounts of fructose often induce malabsorption that causes gastrointestinal symptoms, for example bloating, abdominal pain and diarrhea [18] [19] [20] . HFCS-sweetened beverages contain approximately 20-30 g/500 mL of fructose 21) . Therefore, we utilized a moderate amount of fructose (0.5 g/kg) that could be ingested daily. The daily fat intake in Japanese adult women is approximately 50 g 10)
. Therefore, the amount of fat loaded in this study (0.35 g/kg) corresponds to approximately 1/3 of the daily fat consumption 13) . We demonstrated in a previous study that the postprandial lipoprotein metabolism can be evaluated in subjects who consume this amount of fat [12] [13] [14] . In daily dietary habits, fructose is usually consumed with fat. For example, some beverages provided by fast-food restaurants, such as milk shakes, contain fat and HFCS. Therefore, we studied the effects of simultaneous ingestion of fructose and fat on post- 
observed following fructose ingestion in the present study 31) . Fructose has the same chemical formula as glucose, namely C6H12O6; however, its metabolism differs markedly from that of glucose due to its almost complete hepatic extraction and rapid hepatic conversion into glucose, glycogen, lactate and fat. A chronically high fructose intake has been shown to cause dyslipidemia and impair hepatic insulin sensitivity 1) . A meta-analysis concluded that a fructose intake of ＞ 50 g/day (i.e., close to the average daily intake in the USA) is associated with increased postprandial TG excursions, while a fructose intake of ＞100 g/day is associated with increased fasting TG levels 32) . Diets containing ＞15% of energy derived from fructose, compared with glucose, are consistently associated with increases in both fasting and postprandial TG concentrations in humans [33] [34] [35] [36] . Chronic consumption of fructose increases the deposition of visceral adipose tissue, while the consumption of glucose results primarily in an increased deposition of subcutaneous adipose tissue 22) . The chronic consumption of fructose is also associated with an increased concentration of small, dense LDL particles 37) . The adverse effects of fructose may be explained by its hepatic metabolism, which is independent from the energy status, leading to unregulated hepatic fructose uptake and increased lipogenesis 22) . As shown in the present study and a study conducted by Chong et al. 7) , after the ingestion of fructose, the peak plasma fructose concentration remains at approximately 10 mg/dL, thus indicating that first-pass hepatic extraction is much higher than that observed in glucose ingestion. In the liver, fructose is metabolized into glyceraldehyde and dihydroxyacetone phosphate. The ability of fructose to bypass the primary regulatory step of glycolysis, the conversion of glucose-6-phosphate to fructose 1,6-bisphosphate controlled by phosphofructokinase, is of key importance. Therefore, while the glucose metabolism is negatively regulated by phosphofructokinase, fructose can continuously enter the glycolytic pathway in an unregulated manner 38) . In the present study, the concentration of apoB(100) was increased in the trial of ingestion of fructose only, and not in the other three trials, thus suggesting that the ingestion of fructose may increase VLDL-apoB100 production in the liver.
Sex differences in fasting plasma TG concentrations are generally attributed to lower VLDL-TG concentrations in women. Increased clearance of VLDL-TG in plasma is responsible for the lower VLDL-TG concentration, whereas a deceased VLDL-apoB100 secretion rate, combined with a shorter residence time that observed following intake of fat only. In addition, the concentration of apoB48 was lower and its peak was earlier (at 2 hours) following intake of glucose combined with fat in our previous study 23) compared with that observed following intake of fructose combined with fat in the present study. These results suggest the retention of CM-R in the circulation following ingestion of fructose combined with fat compared with that observed following ingestion of glucose with fat. Delayed CM secretion from the intestine depends on differences in the absorption mechanisms of fructose and glucose. Fructose is transported into enterocytes through a specific fructose transporter, GLUT-5, located in the intestinal membrane. The absorption of fructose via facilitated diffusion, which does not require adenosine 5'-triphosphate, differs from that observed in the glucose absorption system 25, 26) . Therefore, the simultaneous ingestion of fructose and fat may have delayed the absorption of fat and the secretion of apoB48-containing TRL particles.
Fructose ingestion is known to acutely suppress plasma FFA and whole-body lipid oxidation 27) . The integrated postprandial inhibition of plasma FFA is of comparable magnitude following the ingestion of equivalent amounts of glucose and fructose, as shown in the present study. The slight increase in plasma insulin elicited by fructose may be sufficient to explain the inhibition of adipose tissue lipolysis, although this increase is quite modest compared with that observed following glucose ingestion.
In addition, the concentration of lactate increased following the ingestion of fructose (but not glucose) or fructose combined with fat. The increased lactate production most likely occurred because the fructokinase activity increased, the rate-limiting step for glycolysis (phosphofructokinase) was bypassed and the pyruvate kinase activity was stimulated by the accumulation of fructose-1-phosphate 28) . However, part of the fructose absorbed into enterocytes may be converted into lactate and released into the portal circulation 1) . In vitro data indicate that lactate rather than triose phosphate is the primary lipogenic precursor stimulated following fructose administration and that activation of pyruvate dehydrogenase by a highfructose diet is a major regulatory step in this process 29) . Simultaneously, fructose inhibits hepatic lipid oxidation, thereby favoring fatty acid reesterification and VLDL-TG synthesis 30) . Triose phosphate produced from fructose is subsequently converted into pyruvate and oxidized into CO2 and H2O in the tricarboxylic acid cycle. A portion of the triose phosphate produced is converted into lactate, accounting for the increase in plasma lactate concentrations of VLDL-apoB100 in plasma, is responsible for the lower VLDL-apoB100 concentrations observed in women 39) . In women, the liver secretes VLDL particles that contain more TG, and are therefore larger, than the VLDL particles secreted by the liver in men. The results of in vivo studies demonstrate faster removal of TG from large, TG-rich VLDL particles than from small, TG-poor particles 40) . The present study demonstrated that the simultaneous ingestion of a moderate amount of fructose and fat, which can be ingested daily, markedly exacerbates postprandial exogenous lipidemia, even in young healthy women. Although postprandial lipidemia is a known risk factor for coronary heart disease 8) , the influence of high fructose intake on health in young women has not been clarified. We are apprehensive of the deleterious effects of fructose ingestion on the health of this population. However, due to the relatively small number of subjects enrolled, the present results should be interpreted with caution.
Conclusion
Our present results demonstrated that the simultaneous ingestion of a moderate amount of fructose and fat markedly exacerbates postprandial exogenous lipidemia in young healthy Japanese women, thus suggesting that even a relatively modest amount of fructose intake may be excessive.
